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Selective breeding programs aiming to increase the productivity and profitability of the
sheep meat industry use elite, progeny tested sires. The broad genetic traits of primary
interest in the progeny of these sires include skeletal muscle yield, fat content, eating
quality, and reproductive efficiency. Natural mutations in sheep that enhance muscling
have been identified, while a number of genome scans have identified and confirmed
quantitative trait loci (QTL) for skeletal muscle traits. The detailed phenotypic characteris-
tics of sheep carrying these mutations or QTL affecting skeletal muscle show a number
of common biological themes, particularly changes in developmental growth trajectories,
alterations of whole animal morphology, and a shift toward fast twitch glycolytic fibers.The
genetic, developmental, and biochemical mechanisms underpinning the actions of some
of these genetic variants are described. This review critically assesses this research area,
identifies gaps in knowledge, and highlights mechanistic linkages between genetic poly-
morphisms and skeletal muscle phenotypic changes.This knowledge may aid the discovery
of new causal genetic variants and in some cases lead to the development of biochemical
and immunological strategies aimed at enhancing skeletal muscle.
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INTRODUCTION
Significant improvement in sheep meat production has recently
been made by using selective breeding and improved animal
husbandry (Fogarty, 2009; Gardner et al., 2010). The breeding
programs typically select sires based on production performance
of their progeny, relatives and ancestors, or combinations thereof.
Genetic selection and breeding using sires with high estimated
breeding values (EBVs) for muscling traits is prevalent in the sheep
meat industry.
DNA marker-assisted breeding strategies in sheep are now posi-
tioned to markedly accelerate the rates of genetic gain for desirable
production traits, especially those that are difficult to measure,
costly, and only expressed late in life. DNA markers in linkage dis-
equilibrium (LD) with causal genetic variants are typically used in
this strategy. Most livestock production traits are complex, involv-
ing contributions from a large number of additive genetic variants
each of small effect size, interactions between genes, and strong
gene by environment influences. To account for the additive con-
tributions from many genes, and perhaps also epistatic effects,
there has been recent focus on the implementation of genomic
selection (or whole genome selection), which is“a form of marker-
assisted selection in which genetic markers covering the whole
genome are used so that all quantitative trait loci (QTL) are in
LD with at least one marker” (Goddard and Hayes, 2007). A DNA
marker-assisted selection strategy, and whole genome selection,
will likely be more accurate and more robust if it incorporates
contributions from causal genetic variations rather than relying
entirely on markers in LD with these variants. Moreover, the dis-
covery of causal variations can often suggest new opportunities for
biochemical and immunological modulation of muscling traits.
The latter strategy has potential for rapid implementation in all
livestock and its impact is likely to be highly predictive and com-
plement the use of genetic markers. These attributes are offset
by its potential cost and the necessity for reintroduction of the
application in each generation.
The rate of discovery of causal genetic variants (quantitative
trait nucleotides or QTN) has been slow in most mammals. This is
due to (i) the inability to efficiently dissect the broad genomic
regions identified as containing QTN, (ii) the typically small
effect sizes of most QTN, (iii) the difficulty providing conclu-
sive proof, which often involves mechanistic investigation, and
(iv) the absence, or only recent availability, of genome sequences
for many domestic animal species (Ron and Weller, 2007; Braun-
schweig, 2010). The bovine genome sequence has been available
since 2009 and an ovine genome sequence will likely be available
in 2012 (Elsik et al., 2009; International Sheep Genomics Consor-
tium et al., 2010). Genome sequences coupled with high density
SNP chips provide opportunity to markedly accelerate discovery of
causal genetic polymorphisms contributing to complex traits, like
muscling. Despite the above limitations, a few causal genetic vari-
ants of relatively large effect sizes impacting on muscling traits have
been discovered. Moreover, novel genetic, developmental, and bio-
chemical mechanisms associated with these genetic variants have
also been revealed.
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The purpose of this review is to summarize this information,
identify gaps in knowledge, and speculate on biochemical and
immunological strategies for enhancement of muscling. Causal
genetic polymorphisms are defined as those directly implicated in
contributions to trait variation. In some instances independently
confirmed genetic markers associated with skeletal muscle traits
are also described, although the underlying causal polymorphisms
are unknown. The impacts on eating quality traits associated with
enhanced muscling in sheep have been recently summarized and
are not discussed in any detail herein (Warner et al., 2010; Hopkins
et al., 2011; Lambe et al., 2011).
SKELETAL MUSCLE FORM AND FUNCTION
To understand the impacts of genetic variants affecting skeletal
muscle traits in livestock, it is important to consider the normal
functions and development of skeletal muscle. Skeletal muscle is
superbly adapted to its functional roles. Muscles undergoing slow
but continuous contractions in the post-natal environment, such
as various postural muscles, are characterized by predominance of
slow twitch fibers (type 1 fibers), which do not tire easily and are
reliant on oxidative metabolism. They have abundant mitochon-
dria and appear reddish in color. In contrast, muscles requiring
rapid contraction generating substantial force, such as some loco-
motory muscles, have a greater proportion of fast twitch fibers
(type IIb and IIx fibers). These muscles largely depend on gly-
colytic metabolism for energy generation and are whiter and have
fewer mitochondria (MacIntosch et al., 2006). The number of
fibers and fiber type composition are set during early to mid
fetal development. During late fetal development and the rapid
post-natal growth period there is extensive muscle fiber hyper-
trophy driven by fusion of mononuclear muscle satellite cells
with multinucleated myofibers (MacIntosch et al., 2006). Satellite
cells are located between the sarcolemma and basal membrane
of muscle fibers, and while normally quiescent in adult mus-
cle, upon muscle injury, they proliferate and fuse with myofibers
thereby aiding repair. Muscle fibers are composed of a number of
highly organized proteins, principally polymeric actin, myosin,
and their ancillary proteins (Tellam, 1985; MacIntosch et al.,
2006).
The transition from the ruminant fetal environment to that
of the newborn is associated with major physiological changes.
Skeletal muscle must rapidly adapt to meet the new demands
of locomotion and postural support against gravity, whilst using
different sources of energy than those available in the uterine envi-
ronment. These adaptations are of great importance to newborn
ruminants as they stand, walk, and run within a few hours of
birth. Ovine skeletal muscle undergoes a major transition late in
its development, which ensures newborn skeletal muscle is largely
characterized by adult skeletal muscle fiber types (Byrne et al.,
2010b). Thus, skeletal muscle is subject to a robust developmen-
tal program upon which is built responsiveness to environment
cues. Mutations affecting muscling (i.e., muscle thickness rela-
tive to skeletal dimensions) typically alter the trajectory of this
developmental program and change muscle fiber number, com-
position, and hypertrophy. Multiple ovine mutations have been
discovered that enhance muscling and act through novel mecha-
nisms impacting on this developmental program (Table 1). These
mutations provide excellent models for studying muscle function
and formation.
THE HERITABILITY OF MUSCLING TRAITS IN PRODUCTION
SHEEP
Sheep muscling traits typically have moderate heritabilities. Vari-
ous Merino and Border Leicester crosses have been examined for
a variety of carcass and muscling traits (Mortimer et al., 2010).
The ranges of heritabilities for muscle weight, meat yield, and
carcass muscle dimensions were 0.22–0.35, 0.24–0.35, and 0.25–
0.34, respectively. For United Kingdom Charollais, heritabilities
for muscle depth and muscle depth corrected for live weight were
0.25 and 0.31, respectively (McRae et al., 2005), while heritabilities
for muscle depth in Texel, Suffock, and Charollais sheep ranged
between 0.38 and 0.54 (Matika et al., 2010). These values are sim-
ilar to an average figure of 0.4, calculated for the muscling trait
longissimus muscle area, in a meta-analysis of 72 studies in cattle
(Utrera andVanVleck, 2004). A number of QTL affecting muscling
traits in various sheep populations have been discovered. Some of
the underlying QTN have been identified, especially genetic vari-
ants with relatively large effect sizes, e.g., the myostatin (MSTN)
and Callipyge mutations. Other QTL, usually of low to moderate
effect sizes, have been confirmed in independent sheep popula-
tions but only localized to broad chromosomal regions containing
many genes.
MYOSTATIN
Myostatin is a potent negative regulator of muscle mass in mam-
mals. It is a member of the TGF-β superfamily of cytokines, several
of which have key roles in maintaining skeletal muscle homeostasis
through regulation of growth, differentiation, and regeneration of
muscle (McPherron and Lee, 1997). Natural mutations in bovine,
human, ovine, caprine, and canineMSTN that either inactivate the
encoded protein or suppress its quantity cause enhanced muscling
(Grobet et al., 1997; McPherron et al., 1997; Clop et al., 2006;
Mosher et al., 2007; Stinckens et al., 2011; Zhang et al., 2012).
Genetic manipulations that inactivate MSTN in transgenic mice
and fish cause a similar phenotype (McPherron and Lee, 1993;
McPherron et al., 1997; Sawatari et al., 2010). MSTN gene poly-
morphisms are also associated with racing speed for specific lines
of horses and dogs (Mosher et al., 2007; Hill et al., 2010). For
the cow, there are multiple mutations in MSTN that enhance
muscling (McPherron and Lee, 1997). Most major skeletal mus-
cles are affected by these mutations, which generally increase
myofibril number (hyperplasia) and to a lesser extent myofiber
cross-sectional area (hypertrophy), and increase the proportion of
fast twitch glycolytic fibers. There are also decreased levels of con-
nective and intramuscular adipose tissues (Bellinge et al., 2005).
The impacts of the mutations are typically larger in homozygous
animals compared with heterozygous animals. In sheep, several
MSTN polymorphisms associated with muscling phenotypes have
been reported (Table 1). The variety of different types of mutations
that inactivate MSTN, particularly in cattle, are noteworthy and
correspondingly there is a range of muscling phenotypes (Joulia-
Ekaza and Cabello, 2006). Thus, there is a wealth of biological
information accompanying MSTN mutations that is common to
many mammalian species.
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Table 1 | Characteristics of genes affecting muscling in sheep.
Gene or QTL Genomic location Characteristics of QTN Breed Phenotypic effect (reference)
Myostatin g+6723G-A SNP in the 3′ untranslated region
of MSTN which generates an
illegitimate miRNA binding site
Texel Enhanced muscling and less fat (Clop et al., 2006;
Johnson et al., 2009; Boman et al., 2010; Masri et al.,
2011a,b)
Myostatin g+6723G-A SNP in the 3′ untranslated region
of MSTN which generates an
illegitimate miRNA binding site
Charollais Increased muscle depth (Hadjipavlou et al., 2008)
Myostatin c.960delG Frame-shift mutation Norwegian White Enhanced muscling and less fat (Boman et al., 2010)
Myostatin Intron 1 – Baluchi Body weight (Ansary et al., 2011)
Callipyge Telomeric region of
OAR18
Intergenic SNP within an
imprinted locus on the telomeric
arm of OAR18 (phenotype only
expressed post-natally by the
paternal heterozygote)
American Dorset Increased size of caudal muscles, leanness, shift
toward type IIx and IIb fibers, increased FCE,
increased toughness (Koohmaraie et al., 1995; Cockett
et al., 1996, 2005; Jackson et al., 1997a,b,c; Freking
et al., 1998a, 1999; Kerth et al., 1999; Siltberg and
Liberles, 2002; Charlier, 2004; Vuocolo et al., 2007;
White et al., 2007)
Carwell 2–6 cM telomeric of
CSSM18 on OAR18
Not imprinted Australian Poll
Dorset
Increased depth of longissimus dorsi; no effect on
fatness; possible change in muscle shape; shift
toward IIb and IIx fibers (Nicoll et al., 1998;
Greenwood et al., 2006)
LoinMax (rib
eye muscling)
2–6 cM telomeric of
CSSM18 on OAR18
– Poll Dorset Enhanced muscling in the loin (Masri et al., 2010)
TM-QTL 2 cM telomeric of
CSSM18 on OAR18
Evidence for paternal expression
of the muscling phenotype
British Texel Enhanced muscling in the loin (Walling et al., 2004;
Macfarlane et al., 2009, 2012; Rius-Vilarrasa et al.,
2009; Matika et al., 2010)
Xinjiang Telomeric region of
OAR18
– Xinjiang Enhanced muscling (Liu et al., 2006)
QTL OAR1 2 QTL located on
OAR1
Likely to be separate genes as
QTL separated by 50 cM
Suffock and
Charollais
Enhanced muscle depth or live weight (Walling et al.,
2004; McRae et al., 2005; Matika et al., 2010)
MYOSTATIN PROTEIN PROCESSING AND SIGNALING
Myostatin is synthesized as a secreted 52 kDa precursor protein,
which is proteolytically processed into the mature 12 kDa MSTN
polypeptide and the 40 kDa N-terminal inhibitory propeptide
(Latency Associated Peptide, LAP; Figure 1). Both the mature
MSTN polypeptide (a dimer) and the latent inactive complex
consisting of the MSTN polypeptide bound to LAP, circulate in
blood (McPherron et al., 1997; Thies et al., 2001). Over-expression
of LAP in mouse results in muscle mass enhancement. This is
due to the ability of LAP to bind MSTN and inhibit its signaling
activity (Li et al., 2010). Several circulating MSTN binding pro-
teins [follistatin, decorin, small glutamine rich tetratricopeptide
repeat (SGT), titan cap, Grb2-associating protein (GASP), follis-
tatin related gene protein (FLRG)] have been identified in mouse.
Over-expression of follistatin or FLRG increases skeletal muscle
mass (Carnac et al., 2007). Presumably, these proteins sequester
the mature MSTN polypeptide and thereby suppress its signaling
capacity. Proof of this mechanism is still required for many of
these proteins.
Myostatin binds to activin type II receptors (ACVR2A and
ACVR2B) and activates the SMAD signaling transduction path-
way resulting in altered transcription of a number of target genes.
MSTN also activates various cyclin-dependent kinase pathways.
This combined intracellular signaling leads to inhibition of the
G1 to S transition in the cell cycle of myoblasts, inhibition of
myoblast differentiation, and inhibition of satellite cell activation
and renewal (Langley et al., 2002; McCroskery et al., 2003). Thus,
the primary role of MSTN is to negatively regulate myogenesis.
Down-regulation or inhibition of MSTN activity during fetal
development is thought to relieve MSTN’s suppression of muscle
satellite cell activation and renewal, thereby promoting myofiber
formation (Joulia-Ekaza and Cabello, 2006). This results in
hyperplasia and to a lesser extent hypertrophy, with the latter
caused by increased fusion of satellite cells with myotubes. The
myofibers typically also have greater representation of type IIb
fibers (Bellinge et al., 2005; Hennebry et al., 2009). It is noteworthy
that the expression of murine MSTN is normally sixfold greater in
predominantly fast versus slow twitch skeletal muscles suggesting
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FIGURE 1 | Diagrammatic representations of myostatin (MSTN ) gene
and protein structures.The gene consists of three exons. The position of the
c. ∗1232 G>A mutation (previously referred to as g+6723 G-A) is shown by
an asterisk. Unshaded regions in exons and mRNA represent the 5′ and 3′
untranslated regions. The lightly shaded region in the prepro-myostatin
protein sequence corresponds to the signal sequence. Also shown is the site
for processing of the promyostatin protein (thick arrow). The mature myostatin
polypeptide forms a dimer held together by a disulfide bond.
that fast twitch myofibers may be more susceptible to inactivating
MSTN mutations (Allen and Loh, 2011). Moreover, murine MSTN
is a positive regulator of MEF2C, a key promyogenic transcrip-
tion factor that normally promotes formation of slow oxidative
fibers. MSTN is also a negative regulator of MYOD, another key
promyogenic transcription factor with preferential expression in
fast twitch glycolytic fibers. Thus, the absence of MSTN results
in decreased MEF2C mediated slow twitch fiber formation and
increased MYOD mediated fast twitch fiber formation (Hennebry
et al., 2009).
RECENT SELECTION FOR MYOSTATIN MUTATIONS
The MSTN gene, which encompasses three exons (Figure 1), and
the signaling pathways through which it operates are conserved
from zebrafish to humans, indicating that its functions are of
ancient evolutionary origin (McPherron et al., 1997). Although
mammals harboring MSTN mutations are usually viable, dystocia
has been reported in some breeds of cattle (Keele and Fahrenkrug,
2001). The similar muscling phenotypes generated in widely dif-
ferent species carrying MSTN inactivating mutations also attest
to the conservation of this muscle regulatory system. MSTN’s pri-
mary biological role may be to limit muscle size in a manner that is
compatible with the size of the skeletal framework of each species.
The prevalence of mutations in the MSTN genes of cattle, sheep,
goats, and to a lesser extent in racing dogs and horses, may reflect
recent intensive artificial selection for muscling traits in these
populations. Phylogenetic analysis measuring the ratios of non-
synonymous to synonymous substitutions (Ka/Ks) indicates that
the MSTN gene is subject to recent positive selection in the bovinae
and caprinae – there is also some evidence for additional positive
selection that predates domestication (Siltberg and Liberles, 2002;
Tellgren et al., 2004; Bellinge et al., 2005). Moreover, the time to the
most recent ancestor has been estimated at less than 400 years for
a number of specific MSTN mutations, thereby inferring recent
positive selection (O’Rourke et al., 2012). Recent, strong selection
for MSTN has also been observed in three separate populations of
Texel sheep (Kijas et al., 2012).
MYOSTATIN MUTATIONS IN SHEEP
Texel sheep are characterized by enhanced muscling compared
with other sheep breeds. In an elegant exemplification of modern
genetic technologies, Clop et al. (2006) identified a QTL of major
effect on muscling located in a 10 cM confidence interval on OAR2
using a Romanov×Texel F2 cross. The QTL accounted for 5–25%
of the phenotypic variance. Fine mapping reduced the interval,
which encompassed MSTN. Sequencing of the 10.5 kbp region of
MSTN for Texel and control animals identified 20 SNP, most of
which were monomorphic in Texel animals and consistent with
a selective sweep across the locus. None of the SNP were located
in the MSTN coding sequence. Analysis of offspring from an F2
ram that inherited an intact Texel chromosome and a recombined
chromosome excluded 18 SNP. One of the two remaining SNP (c.
∗1232 G>A, but previously denoted g+ 6723 G-A) was virtually
Texel specific in the A allele and located in the 3′ UTR of MSTN
mRNA (Figure 1). The variant created an illegitimate motif poten-
tially recognized by three miRNA (miR-1,miR-206, andmiR-122a;
Figure 2). Two of the miRNA,miR-1, and miR-206, were known to
be strongly expressed in skeletal muscle. Consistent with a miRNA
mediated mechanism, the total level of circulating MSTN was
about one third of that in wild type sheep, although the mRNA
level in skeletal muscle was unaffected. Further experiments using
reporter constructs transfected into COS1 cells unambiguously
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FIGURE 2 | Alignments of the ovine miR-1 and miR-206 sequences
with the region in the 3′ UTR of wild type ovine MSTN where the c.
∗1232 G>A mutation (underlined) occurs. Bolded nucleotides show
complementarity of miR-1 and miR-206 with the MSTN 3′ UTR (center
sequence). The eight nucleotide seed regions in the 5′ end of the miRNA
are boxed. The G to A mutation produces an illegitimate recognition site
for these miRNA and miRNA mediated translational repression of MSTN
mRNA.
proved that the A allele created an illegitimate miRNA binding
site in the 3′ UTR of MSTN mRNA allowing miRNA mediated
translational repression. The effect of the mutation on muscling
traits has been independently confirmed in a number of sheep
breeds and crosses: Charollais, New Zealand Texel, Norwegian
White, Texel×Poll Dorset cross, and Texel×Welsh Mountain
cross (Hadjipavlou et al., 2008; Johnson et al., 2009; Boman et al.,
2010; Masri et al., 2011a,b).
Additional mutations in the ovine MSTN gene affecting
muscling have been described but in less detail. One frame-
shift mutation (c.960delG) in Norwegian White Sheep resulted
in increased muscling and less fat and these effects were stronger
than in animals carrying the c. ∗1232 G>A mutation (Boman
et al., 2009, 2010). There is also evidence for additional but as
yet uncharacterized mutations possibly located in the promoter
region, intron 1, intron 2, or 3′-UTR of MSTN in various sheep
populations (Kijas et al., 2007; Hickford et al., 2010; Ansary et al.,
2011).
Myostatin mutations have pleiotropic effects in cattle and this
may also be expected in other mammalian species, including sheep.
While increased muscularity and leanness are the most obvious
phenotypes in ruminants, the mutation in cattle can also cause
decreased sizes of several organs, fineness of limb bones, a higher
incidence of underdeveloped genitalia, enlarged tongues, reduced
fertility, low calf viability, increased stress susceptibility, and dysto-
cia (Bellinge et al., 2005). These broad phenotypic effects suggest
perturbation of normal system-wide development, which is most
likely initiated in the embryo or early fetus, and accentuated during
the period of rapid late fetal and post-natal growth.MSTN mRNA,
while strongly expressed in skeletal muscle, is also expressed at
lower levels in a number of adult tissues including adipose and
mammary tissues. Therefore, inactivating MSTN mutations may
directly affect other tissues, besides skeletal muscle (McPherron
et al., 1997). In this regard, the change in body conformation
and carcass “compactness” of sheep carrying the c. ∗1232 G>A
MSTN mutation may be consistent with this concept (Boman
et al., 2010; Masri et al., 2011b). Sheep carrying MSTN mutations
are in widespread use in the sheep meat industry.
BIOCHEMICAL AND IMMUNOLOGICAL STRATEGIES TO ENHANCE
MUSCLING BY SUPPRESSION OF MYOSTATIN ACTIVITY
There are a number of strategies that might be employed to
enhance muscling by exploiting the genetics and biological func-
tions of MSTN. First, because MSTN is a negative regulator
of myogenesis, biochemical, and immunological intervention
strategies designed to directly suppress MSTN activity may
enhance muscling. Indeed, immunization of mice and pigs against
MSTN induced neutralizing humoral immune responses that
enhanced muscling (Tang et al., 2007; Long et al., 2009; Zhang
et al., 2011). A key to success of this approach may be the gener-
ation of sustained, neutralizing IgG responses. Other comparable
approaches involve the use of antibodies blocking binding of
MSTN to the activin type II receptors, dominant negative forms
of the receptors, or dominant negative forms of the mature MSTN
polypeptide (Siriett et al., 2007). In addition, exogenous LAP, fol-
listatin, or FLGR could be used to sequester MSTN and enhance
muscling, as demonstrated in mouse models (Carnac et al., 2007).
In a variation on this strategy, histone deacetylase inhibitors could
be used, as these have been shown to increase follistatin expres-
sion and enhance muscle repair in mice (Minetti et al., 2006).
The limiting features of these approaches are likely to be con-
sumer acceptability, duration of efficacy, cost, and frequency and
timing of administration. These interventions may also need tar-
geting to critical windows of fetal skeletal muscle development.
Second, transgenic modifications using targeted mutagenesis of
MSTN, RNAi directed at MSTN mRNA or over-expression of
proteins that sequester MSTN can be envisaged (Tessanne et al.,
2006). The remarkable quadrupling of skeletal muscle mass in a
murine transgenic mouse engineered to have a MSTN knock-
out and over-expression of follistatin highlights the enormous
plasticity of skeletal muscle and its potential for enhancement in
livestock (Lee, 2007). Thus, direct interventions in MSTN signal-
ing and its regulatory pathways are likely to have strong potential
for enhancing muscling in livestock.
CALLIPYGE
The Callipyge mutation in sheep has provided remarkable new
insights into genetics, regulation of gene expression and biol-
ogy. The mutation causes skeletal muscle hypertrophy, but only in
paternal heterozygous animals (NmatCpat; N, is the wild type allele
and C is the allele carrying the mutation); a characteristic termed
polar over-dominance (Cockett et al., 1996). The maternal het-
erozygote (CmatNpat) and homozygote (CmatCpat) animals show
no muscling phenotypes. Specific skeletal muscles in the NmatCpat
genotype are increased in size by as much as 35%, although
increased meat toughness has prevented commercial exploitation
of these animals (Koohmaraie et al., 1995; Jackson et al., 1997a,b,c).
In affected muscles, there is a marked shift toward type IIb and IIx
fibers with a corresponding decrease in type I fibers, decreases
in the proportional sizes of several non-muscle organs, increased
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leanness, and improved feed conversion efficiency (Jackson et al.,
1997a,b,c; Charlier, 2004; Vuocolo et al., 2007; White et al., 2007).
Live weight is unaffected and carcasses are more compact with
a shorter length and greater width at the shoulder and rump
(Freking et al., 1998a).
Unlike MSTN mutations, not all major muscles are affected by
the Callipyge mutation. The muscling phenotype is first expressed
1–3 months post-birth and this occurs along a rostro-caudal gra-
dient in the NmatCpat animal, with greatest impact on skeletal
muscles innervated through lumbar and sacral roots, e.g., longis-
simus dorsi and semimembranosus muscles (Koohmaraie et al.,
1995; Freking et al., 1998a,b, 1999; Kerth et al., 2003; Cockett
et al., 2005). As a consequence of the post-natal development of
the phenotype, there is no increased risk of dystocia in NmatCpat
lambs. The muscling phenotype is maintained throughout adult
life.
CHANGES IN EXPRESSION OF IMPRINTED GENES SURROUNDING THE
CALLIPYGE MUTATION
The causative point mutation (A/G) responsible for the Callipyge
muscling phenotype has been located in a 12 bp conserved motif
positioned near the telomeric end of OAR 18 between the protein
encoding gene DLK1 (delta-like 1) and the non-protein encod-
ing gene GTL2 (gene trap locus 2; or MEG3; Figure 3; Freking
et al., 2002; Smit et al., 2003). The ram in which the muta-
tion first arose was a germ line mosaic for the mutation (Smit
et al., 2003). The broader ∼1 Mbp region defines a cluster of
conserved imprinted genes (Figure 3; Schmidt et al., 2000; Char-
lier et al., 2001a,b; Seitz et al., 2003; Takeda et al., 2006; Byrne
et al., 2010a). The expression patterns of the core group of these
imprinted genes are strikingly perturbed in affected skeletal mus-
cles from NmatCpat lambs, but are normal in unaffected muscles
or the other genotypes (Bidwell et al., 2001, 2004; Charlier et al.,
2001a; Murphy et al., 2005; Vuocolo et al., 2005, 2007; Fleming-
Waddell et al., 2007, 2009; White et al., 2007; Caiment et al., 2010).
Thus, altered gene expression at this imprinted locus is tightly
linked with emergence of the phenotype. The affected genes span
a core region of∼350 kbp and includeDLK1,GTL2,PEG11 (pater-
nally expressed gene 11; also known as retrotransposon like 1
(RTL1)), PEG11AS (antisense to PEG11; also known as RTL1AS),
MEG8 (maternally expressed gene 8) and MIRG (micro RNA-
containing gene). While the expression of these genes is altered,
their imprinted status remains unchanged. DLK1 and PEG11 are
paternally expressed and both encode proteins, while the remain-
der are maternally expressed non-coding genes. The latter are all
expressed from the same strand. GTL2 expresses a large number
of splice variants of a long non-coding RNA. MIRG encodes at
least 50 miRNA, while MEG8 encodes a cluster of CD snoRNA.
As the muscling phenotype is only expressed in NmatCpat ani-
mals, it was reasoned that the markedly enhanced expression of
one (or both) of the paternally expressed protein encoding genes,
DLK1 or PEG11, was the primary driver of the muscling phe-
notype (Charlier, 2004). The mutation also enhances expression
of the maternally expressed genes in NmatCpat animals (Vuocolo
et al., 2005). However, these effects are relatively small compared
with their enhanced expression in the CmatNpat and CmatCpat
genotypes, both of which do not express a muscling pheno-
type. Hence, these genes are unlikely to be directly promoting
the phenotype.
It has been postulated that normal post-natal down-regulation
of imprinted genes acts to coordinate the post-natal growth decel-
eration in many tissues (Lui et al., 2008). The Callipyge mutation in
NmatCpat animals prevents the normal post-natal down-regulation
of DLK1 and PEG11 in skeletal muscle and recapitulates their
fetal-like gene expression programs (Murphy et al., 2005; White
et al., 2007). The dosage of these imprinted genes may be hav-
ing major effects on the developmental program, and indeed for
murine Dlk1 there is evidence for an optimum dosage that fixes
the upper limit of its growth promotion (da Rocha et al., 2009).
There was no effect of the Callipyge mutation on the expression
ratio of the two major DLK1 splice variants in sheep skeletal mus-
cle, even though there is a strong developmental switch in their
usage (Vuocolo et al., 2005, 2007). The switch occurs during early
to mid fetal development and long before the expression of the
Callipyge phenotype a few weeks after birth. The splice variation
produces a shorter plasma membrane-bound protein (predomi-
nant in the post-natal state) and a longer membrane-bound form
(predominant in the early fetus). The latter is subject to proteolytic
processing releasing a circulating form of DLK1 (Vuocolo et al.,
2003).
FIGURE 3 | Diagrammatic representation of the organization of
imprinted genes located at the telomeric end of ovine chromosome
18.The diagram shows a representation of the ∼1 Mbp region from
BEGAIN to DIO3. The core imprinted genes affected by the Callipyge
mutation are colored while imprinted genes unaffected by the mutation
are shown in gray. Affected paternally and maternally expressed genes
are shaded blue and pink, respectively. The direction of transcription for
each gene is indicated by an arrow. Introns are not shown. The asterisk
denotes the position of the Callipyge mutation (CLPG). The precise
lengths of the maternally expressed genes, which all produce
non-coding RNA, are unclear. The diagram is based on that deduced by
(Georges et al., 2003) supplemented with annotation for a miRNA
cluster (MIRG) deduced by comparative sequence analyses with
orthologous murine and human sequence regions. A larger population of
miRNA scattered throughout the core region has been omitted for clarity
(Caiment et al., 2010).
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THE PRIMARY EFFECTOR GENE DRIVING MUSCLE HYPERTROPHY IN
CALLIPYGE SHEEP
There is significant evidence indicating that DLK1 is the effector
of the muscle hypertrophy phenotype in Callipyge sheep. First, the
increased expression of DLK1 as a function of genotype, develop-
ment, muscle type, and muscle fiber type is strongly associated
with the expression of the hypertrophy phenotype (Charlier et al.,
2001a; Perkins et al., 2006; Fleming-Waddell et al., 2007; Vuo-
colo et al., 2007; White et al., 2007). In particular, this type 1
membrane-bound glycoprotein has increased expression in hyper-
trophied type IIb muscle fibers of the NmatCpat genotype (Charlier
et al., 2001a; Charlier, 2004; White et al., 2007). Second, trans-
genic mice over-expressing Dlk1 using a myosin light chain 3F
promoter were characterized by mild skeletal muscle hypertrophy
(Davis et al., 2004). Third, DLK1 has been implicated in the con-
trol of proliferation and differentiation of many cell types (Wang
and Sul, 2009) and is thought to be an atypical repressive ligand
for the NOTCH signaling pathway. This is a key pathway neg-
atively regulating cell commitment and differentiation (Vuocolo
et al., 2007). Fourth, NmatCpat myoblasts grown in cell culture
and induced to differentiate do not become hypertrophic, but
they also do not express DLK1 (Lavulo et al., 2008). Fifth, con-
sistent with the identification of DLK1 expressing mononucleated
PAX7+ cells (muscle satellite cells) in fetal NmatCpat skeletal mus-
cle, over-expression of Dlk1 in murine skeletal muscle satellite
cells inhibited their proliferation and enhanced differentiation
into multinucleated myotubes (White et al., 2007; Waddell et al.,
2010). Sixth, genetic ablation of Dlk1 in the murine myogenic lin-
eage caused reduced body weight, reduced skeletal muscle mass,
and impaired muscle regeneration, and in cultured satellite cells
ablation promoted satellite cell self-renewal (Waddell et al., 2010).
Over-expression of DLK1 on the surface of the multinucleated
myotubes in some post-natal NmatCpat skeletal muscles may be
driving the characteristic hypertrophy of these muscle fibers. One
model involves over-expression of DLK1 by nascent or regenerat-
ing myofibers which promotes the differentiation of neighboring
satellite cells thereby leading to muscle hypertrophy (Waddell et al.,
2010).
Despite the strong evidence for a direct role of DLK1 in ini-
tiating hypertrophy there is inconsistent information. First, a
murine Dlk1 knockout resulted in obesity but no reported effect
on muscling (Moon et al., 2002). Second, constitutive expression
of Dlk1 in the murine myogenic cell line, C2C12, which does not
express endogenous Dlk1, did not promote differentiation into
multinucleated myotubes (Smas and Sul, 1993). Third, consti-
tutive over-expression of Dlk1 using its endogenous regulatory
elements in transgenic mice resulted in growth enhancement but
the mice failed to survive early life and showed no reported signs of
muscle hypertrophy (da Rocha et al., 2009). These contradictory
results may reflect the use of different experimental species and
models and, in some cases, the lack of primary focus on skeletal
muscle phenotypes. Species specific differences seem an unlikely
explanation since the imprinted gene locus is highly conserved in
placental mammals.
The paternally expressed genePEG11 is an alternative candidate
for the effector. PEG11 is a conserved Ty3-Gypsy retrotransposon
like gene with a single long open reading frame encoding a 1,333
amino acid protein with retroviral gag-pol type structure. The
gene is not associated with long terminal repeats and many of its
encoded retroviral-like protein domains contain mutations that
collectively destroy retrotransposon activity (Byrne et al., 2010a).
The conservation of PEG11 in placental mammals, and its absence
from syntenic chromosomal regions of non-placental mammals,
suggests that during evolution the newly retrotransposed gene
was co-opted for novel functional roles within placental mammals
(Lynch and Tristem, 2003). The full length PEG11 protein has been
identified in nuclear fractions from Callipyge semimembranosus
skeletal muscle (Byrne et al., 2010a). The biological role of PEG11
remains unclear although it has been implicated in angiogenesis
during murine placentation (Sekita et al., 2008).
Like DLK1, the increased expression of PEG11 as a function of
genotype, development, and muscle type is also strongly correlated
with the hypertrophy phenotype (Charlier et al., 2001a; Bidwell
et al., 2004; Perkins et al., 2006; Vuocolo et al., 2007; White et al.,
2007). PEG11 is up-regulated about 45-fold in affected skeletal
muscles from NmatCpat animals at 3 months of age. In comparison,
DLK1 is up-regulated about 6- to 10-fold (Charlier et al., 2001a;
Bidwell et al., 2004; Vuocolo et al., 2005, 2007; Byrne et al., 2010a).
As discussed below, the maternally expressed gene PEG11AS con-
tains a number of miRNA that cause RNA-induced silencing com-
plex (RISC)-mediated cleavage of the paternally expressed PEG11
transcript (Davis et al., 2005). Thus, if PEG11 was the effector
driving the muscling phenotype, there is an obvious mechanism
that could explain the lack of phenotype in homozygote animals.
The potential role of PEG11 in inducing the muscling phenotype
could be directly tested by its over-expression in transgenic mouse
skeletal muscle or myogenic cells. This could be achieved by direct
over-expression of PEG11 or by suppression of PEG11AS, and
hence suppression of miRNA targeting PEG11. It is also possible
that over-expression of both PEG11 and DLK1 are required to
induce muscle hypertrophy. This hypothesis could also be tested
in similar ways in transgenic mice.
It is difficult to envisage how the putative effectors, PEG11 or
DLK1, could be used in direct biochemical and immunological
interventions to enhance muscling. Both putative effectors posi-
tively enhance muscling and hence any intervention must induce
increased levels of these proteins and they must be specifically
targeted to skeletal muscle to avoid potential effects in other tis-
sues. While exogenous soluble DLK1 may be introduced into an
animal, it is unclear whether it would affect muscling as DLK1
may need cell surface presentation to responsive muscle cells. The
intracellular location of PEG11 precludes a similar approach. Var-
ious genetic manipulations within this imprinted locus in mice
have dramatic effects on gene expression at the locus and typically
result in embryonic or fetal lethality (da Rocha et al., 2009). Con-
sequently, it is likely that any exogenous effector will need to be tar-
geted to skeletal muscle and expressed in a specific developmental
window.
A MODEL FOR THE INHERITANCE OF THE CALLIPYGE PHENOTYPE
There are unusual genetic mechanisms associated with the inher-
itance of the Callipyge phenotype, as the hypertrophy phenotype
is only expressed by NmatCpat animals (Cockett et al., 1994; Car-
penter et al., 1996; Jackson et al., 1997a; Freking et al., 1998a,b;
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Bidwell et al., 2004). An elegant genetic model has been developed
to explain this observation (Charlier et al., 2001a; Georges et al.,
2003). The model proposes that the balance between the activi-
ties of a paternally expressed effector and a maternally expressed
trans-acting repressor dictates the phenotypic outcome. The latter
may exert its effects by translational suppression of the effec-
tor. In the NmatCpat genotype the paternally expressed effector
gene is influenced by the mutation acting in cis, thereby causing
its over-expression relative to the maternally expressed repres-
sor. The excess influence of the effector over repressor in this
genotype induces muscle hypertrophy. Conversely, for CmatNpat
animals, where the animals are phenotypically normal, the muta-
tion acts in cis to increase expression of the maternally expressed
repressor, but it has no influence as the effector is not expressed
from the wild type paternal allele. In the homozygote the pater-
nally expressed effector and maternally expressed repressor are
both up-regulated, but the influence of the effector does not
dominate the repressor, and therefore no change in phenotype
is generated.
The nature of the trans-acting maternally expressed repressor
in this model is unclear although it is noted that only non-coding
RNA are maternally expressed from the core of this imprinted
locus (Charlier et al., 2001a). These non-coding genes are strongly
up-regulated in the CmatNpat and CmatCpat genotypes, both of
which do not express muscling phenotypes. In this regard, the
PEG11AS transcript encodes six miRNA, which cause RISC-
mediated cleavage of PEG11 (Davis et al., 2005). Hence, these
miRNA are ideally placed to act as maternally expressed trans-
acting repressors of paternally expressed PEG11. In this model
PEG11 is the putative effector of the phenotype.
An alternative, but analogous mechanism involves some of the
approximately 110 likely maternally expressed miRNA that map
to the core of the imprinted domain, and in particular a subset
of approximately 50 miRNA encoded by the maternally expressed
non-coding gene,MIRG (Glazov et al., 2008; Caiment et al., 2010).
Some MIRG miRNA are predicted to target DLK1 and many of
these miRNA are up-regulated in cis with the Callipyge mutation
(Hagan et al., 2009; Caiment et al., 2010). Experimental defini-
tions of the targeting specificities for these maternally expressed
miRNA are required to substantiate this hypothesis. It will also be
important to define whether these miRNA act by RISC-mediated
cleavage or translational repression of DLK1. A counterpoint to
this mechanism is that many of the miRNA in this imprinted
region show substantially increased expression in the CmatNpat
and CmatCpat genotypes, which display no muscling phenotype.
This result implies the effector is not expressed and there are
no other mRNA targets for these miRNA in skeletal muscle cells
from animals with these genotypes, despite the number of miRNA
expressed from this region and their predicted broad mRNA tar-
get specificities. One possibility is that the primary role of these
miRNA may involve maintenance of imprinting status at this locus
rather than regulating mRNA. Intriguingly, the Callipyge muta-
tion acting in trans, also causes a small increase in the expression
of these maternally expressed miRNA, as it does forGTL2, suggest-
ing that there is much more to learn about the complex regulatory
events occurring within this imprinted gene locus (Caiment et al.,
2010).
MECHANISMS CAUSING MUSCLE HYPERTROPHY IN CALLIPYGE SHEEP
Microarray analyses of affected skeletal muscles have been under-
taken to gain insight into the mechanism underlying generation of
the hypertrophy phenotype in Callipyge lambs (Fleming-Waddell
et al., 2007; Vuocolo et al., 2007). In one model generated from
these studies, increased expression of DLK1 on myofibrils sup-
presses the myogenic inhibitory effects of the NOTCH signaling
pathway in adjacent satellite cells, possibly in conjunction with
suppression of HDAC9 (histone deacetylase 9), a known nega-
tive regulator of myogenesis (Vuocolo et al., 2007). This promotes
satellite cell activation and their fusion with adjacent multinucle-
ated myotubes thereby generating larger hypertrophied myotubes.
The discovery that DLK1 is expressed on the cell surface of a subset
of mononuclear satellite cells and on the surface of multinuclear
myofibers in NmatCpat skeletal muscle supports this possibility
(White et al., 2007; Waddell et al., 2010). Another investigation
suggested that activation of the AKT/mTOR signaling pathway
was the primary driver of enhanced protein synthesis in mus-
cles affected by the mutation (Fleming-Waddell et al., 2009). Both
AKT/mTOR and HDAC9 are known to be important regulators
of myogenesis and muscle hypertrophy in mouse models (sum-
marized in Fleming-Waddell et al., 2007, 2009; Vuocolo et al.,
2007).
INTERPLAY BETWEEN THE CALLIPYGE MUTATION AND EPIGENETIC
MARKS
How does the Callipyge mutation act over considerable genomic
distances to cause changes in gene expression within the core of
the imprinted domain? A clue to the mechanism whereby the Cal-
lipyge mutation, acting in cis, increases expression of a number of
adjacent imprinted genes can be found in changes to DNA methy-
lation surrounding the site of the mutation. In post-natal NmatCpat
samples from affected, but not unaffected, muscles, the wild type
allele is strongly methylated but the Callipyge allele is hypomethy-
lated (Murphy et al., 2006). The mutation is also associated with
development of novel DNase-I hypersensitivity sites, indicating
increased relaxation of the chromatin state (Takeda et al., 2006).
Consistent with this permissive epigenetic state, the mutation, act-
ing in cis, causes bidirectional long range DLK1-GTL2 intergenic
transcription of non-coding RNA in the lamb (Takeda et al., 2006).
The conserved 12 bp motif, in which the mutation is located, is
normally likely to be a long range regulatory element, possibly
an insulator or enhancer, that exerts developmental and tissue
specific controls on the expression of multiple genes in the core
of the imprinted region. The mutation is presumed to perturb
these roles by changing binding affinity for key transcriptional co-
regulators thereby preventing the normal program of post-natal
down-regulation of imprinted genes in this region. The mutation
also exerts influence in specific muscles toward the rear of the
animal possibly through the actions of a rostro-caudal position-
ally graded regulator, whose pattern of expression is set early in
embryonic development.
The polar over-dominant inheritance pattern characteristic of
the Callipyge muscling phenotype is more widespread in mammals
than widely appreciated. In pigs, the same locus is associated with
growth, fatness, and body composition in a polar over-dominant
manner (Kim et al., 2004; Oczkowicz, 2009). In humans, a SNP,
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rs1802710 situated in exon 3 ofDLK1, is associated with polar over-
dominant expression of child and adolescent obesity (Wermter
et al., 2008). Another SNP, rs941576, located withinGTL2 is associ-
ated with paternally inherited risk of type 1 diabetes (Wallace et al.,
2010). Notably, Dlk1-null mice show growth retardation, acceler-
ated obesity, and hyperlipidaemia (Moon et al., 2002). A genome
scan for imprinted body weight and growth QTL in mice has iden-
tified additional unusual inheritance patterns at a variety of loci
elsewhere in the genome (Wolf et al., 2008). These patterns include
bipolar over-dominance (the two heterozygotes differ from each
other but the two homozygotes have similar phenotypes), and
polar under-dominance (one of the two heterozygotes exhibits a
lower intensity of phenotype compared to the other three geno-
types). Widespread allelic imbalance in gene expression and DNA
methylation are likely to be the norm and not the exception (Kong
et al., 2009; Meaburn et al., 2010). Some of this imbalance will be
due to allelic contributions and trans-acting epistatic effects, while
other contributions are likely to reflect epigenetic based parent-of-
origin effects and generalized monoallelic gene silencing. Unless
expressly tested, these non-Mendelian effects are likely to have been
missed in current genome-wide trait association analyses (Matika
et al., 2010). Re-analysis of existing datasets using a broader range
of genetic models is warranted, as this may reveal new QTL with
non-Mendelian behavior and simultaneously enhance sensitivity
to detect standard QTL.
CONFIRMED QUANTITATIVE TRAIT LOCI FOR MUSCLING IN
SHEEP
In addition to highlighting the contributions of MSTN polymor-
phic variants to muscling phenotypes, several genome scans in
different populations of sheep have identified QTL for muscling
on the telomeric end of OAR 18. These are different from the
effects of the Callipyge mutation, but located at the same general
position (Cockett et al., 2005).
CARWELL, LOINMAX™ AND OTHER MUSCLING QTL LOCATED ON THE
TELOMERIC ARM OF OAR18
The Carwell (or rib eye muscling, REM) locus identified in Aus-
tralian Poll Dorset rams is associated with increased muscle depth
of longissimus dorsi (also named longissimus lumborum) with no
effect on fatness or live weight. There is also a change in muscle
shape and a shift from type IIa towards type IIb and IIx muscle
fibers (Nicoll et al., 1998; Greenwood et al., 2006). The QTL is posi-
tioned 2–6 cM telomeric to the CSSM18 marker on OAR18 and
overlaps with the site of the Callipyge mutation. The effect of each
allele was additive and dominant, and there was no indication that
the QTL was imprinted; however, this possibility was not explicitly
tested. The effects of this QTL are relatively small and more vari-
able compared with Callipyge. Recently, a QTL (LoinMAX™) for
the same muscling trait was located within this genomic interval in
a cross between Poll Dorset heterozygous ram carriers and British
cross-bred ewes (Masri et al., 2010). In this instance, there was a
small extent of enhanced muscling and no effects on carcass lean
weight, fat content or body conformation scores.
In Texel and Texel–Suffolk families another confirmed muscling
QTL (TM-QTL) was localized to 2 cM telomeric of the same
marker (CSSM18) on OAR18 (Walling et al., 2004; Macfarlane
et al., 2009, 2012; Rius-Vilarrasa et al., 2009; Matika et al., 2010).
The muscling phenotype in these animals was similar to that in the
Poll Dorset sheep and associated with altered muscle shape – the
carcass was described as more “compact.” It was recently con-
cluded there is evidence for imprinting of this QTL. It showed a
polar over-dominance model of inheritance suggesting similarity
with the Callipyge mutation, albeit the muscling effect size of the
QTL was much smaller (Matika et al., 2010). In a fourth example,
a polymorphism in this same region was associated with muscling
traits in Xinjiang sheep (Liu et al., 2006). It is likely that discern-
ment of finer details of the muscling phenotypes and inheritance
patterns in these four sheep populations is limited by the relatively
small muscling effect sizes of these QTL.
The causal genetic polymorphisms linked with these QTL are
unknown although they are unlikely to be directly related to the
Callipyge mutation for the following reasons. (i) Direct examina-
tion of DNA sequence at the site of the Callipyge mutation does not
reveal any sequence variation in the Texel or Xinjiang animals (Liu
et al., 2006; Matika et al., 2010). (ii) The absolute effects on spe-
cific muscles were much weaker for these QTL (∼2.5–7% increase
in muscling compared with up to 35% in some muscles from
Callipyge sheep), and effects on fat depth and muscle tenderness
were also quantitatively different. The pronounced rostro-caudal
muscling gradient in Callipyge animals was also not apparent in
these other populations. (iii) Callipyge has a complex inheritance
pattern that was not readily apparent for all of these QTL, with the
exception of the Texel QTL (Matika et al., 2010). Carwell shows a
simple autosomal dominant pattern of inheritance (Jopson et al.,
2001), although there has been an unconfirmed suggestion of sire-
dependent effects in the progeny of LoinMAX™ animals (Nicoll
et al., 1998). The pathway to commercial exploitation of these QTL
will critically depend on whether or not they are imprinted, as this
will have a strong influence on breeding flock design. A homozy-
gote terminal sire would likely be used. All progeny from this sire
would inherit one active copy of the imprinted gene because of the
paternal transmission mechanism. QTL for muscle depth and live
weight have been also located on OAR1 in Suffock and Charollais
populations, respectively (Walling et al., 2004; McRae et al., 2005;
Matika et al., 2010). The QTL lie 50 cM apart and are therefore
unlikely to be caused by polymorphisms in the same genes. The
corresponding QTN have not been defined.
INTEGRATION OF GENE EXPRESSION WITH GENETIC
ARCHITECTURE ASSOCIATED WITH ENHANCED MUSCLING
Muscle accretion is the result of contributions from a number
of developmental and biochemical pathways. Multiple genetic
variants in these pathways, acting in concert, are likely to under-
pin enhanced muscling traits in most production populations,
particularly in the absence of genetic variants of relatively large
effect sizes, e.g., the Callipyge and MSTN mutations. The impacts
of these multiple genetic variants, each of small effect size, can
be measured through their combined influence on these path-
ways. Using Poll Dorset sheep, the pathways associated with the
genetics of enhanced muscling were identified by linking gene
expression patterns in progeny skeletal muscle with sire based
EBVs for the muscling trait, longissimus dorsi depth (Kogelman
et al., 2011). In this study there was strong sire based genetic
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structure associated with the gene expression program in prog-
eny skeletal muscle. Higher sire EBV was also probably asso-
ciated with a shift toward fast twitch glycolytic fibers in prog-
eny. It was concluded that sires with high muscling EBVs were
characterized by progeny muscle accretion mediated by activa-
tion of pathways that include enhanced myogenesis, muscle fiber
hypertrophy, and decreased protein catabolism. Low EBV status
resulted from increased genetic contribution to protein degrada-
tion pathways. As may be expected, the key genetic effects dictating
EBV status impacted on the balance between muscle fiber pro-
tein accretion and turnover. This type of analysis, particularly
if coupled with SNP association data, has potential to acceler-
ate the identification of additional genetic variants contributing
to muscling by the discovery of pathways directly contributing
to muscling traits. The analysis may also be particularly suited
to dissection of complex traits. One strength of this approach
is that the application of RNA-seq could allow identification of
genes demonstrating allelic expression imbalance. This is a sig-
nature for a cis-acting SNP regulating gene expression (excluding
imprinted genes). These SNP could be directly contributing to the
trait.
CONCLUSION
A number of genetic variants with confirmed effects on muscling
in sheep have been discovered. There are several common features
associated with a high muscling phenotype in sheep irrespective
of the primary genetic driver. (i) Enhanced muscling is often asso-
ciated with morphology change of the animal. This suggests a
common change in developmental programming that scales body
shape to accommodate enhanced skeletal muscle structure. (ii)
Changed developmental trajectories for skeletal muscle beginning
in early life are also common and these may be linked with mor-
phology changes. (iii) Large increases in muscularity are typically
associated with a shift toward fast twitch glycolytic fibers, lean-
ness, and poorer eating quality attributes. The reasons for these
changes are unclear, although both myoblasts and preadipocytes
have a common progenitor cell, suggesting a developmental link.
(iv) The mutations associated with MSTN and Callipyge are typ-
ically recent and for MSTN there has been strong and positive
selection in production flocks. (v) The co-occurrence in Texel
sheep of a recent mutation in MSTN contributing to muscling,
as well as a confirmed QTL for muscling on the telomeric end of
OAR18, indicates that artificial breeding programs have enriched
for genetic variants with independent and additive effects. This
suggests the involvement of fundamental and independent reg-
ulatory mechanisms that presumably normally function to limit
muscle growth.
The immediate future of the sheep meat industry will, see
the increasing exploitation of natural genetic variation contribut-
ing to muscling. The incorporation of causal genetic variations
into genomic selection strategies will enhance their accuracy and
robustness, while allowing targeted selection to achieve more rapid
genetic improvement. In the medium term, the discovery of devel-
opmental and biochemical pathways contributing to enhanced
muscling will open new opportunities for the use of novel and
acceptable biochemical and immunological interventions that may
play a significant and complementary role to genetic selection in
the sheep meat industry.
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